search
Back to results

Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia

Primary Purpose

Multiple Sclerosis, Dysphagia, Swallowing Disorder

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
DYMUS
Sponsored by
Tuba Maden
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Multiple Sclerosis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. being diagnosed with Mc Donald's Multiple sclerosis (MS) in accordance with 2010 criteria,
  2. being between the ages of 18-45.

Exclusion Criteria:

  1. having psychological, orthopedic and other neurological disorders,
  2. pregnancy,
  3. having had an attack in the last 3 months,
  4. application of botulinum toxin in the last 6 months.

Sites / Locations

  • Hasan Kalyoncu University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Other

Other

Other

Arm Label

without swallowing problem

mild swallowing problem

severe swallowing problem

Arm Description

patients without swallowing problem

patients with mild swallowing problem

patients with severe swallowing problem

Outcomes

Primary Outcome Measures

Myotonometric Measurement
MyotonPro® device was used to measure muscles' viscoelastic parameters. The device is valid and reliable for measuring viscoelastic parameters (5, 6). Tonus, stiffness, elasticity of the muscles were recorded. Three measurements were bilaterally taken for each muscle. For each muscle, the average values of stiffness, tone and elasticity were retained as the main MyotonPRO outcomes. Myotonometric measurements were carried out for Masseter, Orbicularis Oris and Sternocleidomastoid (SKM) in supine position.

Secondary Outcome Measures

Eating Assessment Tool
Eating Assessment Tool was used to assess symptom of dysphagia. EAT-10 consisted of ten items, each of items was scored from 0 to 4. As the score increases, the patient's symptoms become deterioration.

Full Information

First Posted
April 27, 2020
Last Updated
April 27, 2020
Sponsor
Tuba Maden
search

1. Study Identification

Unique Protocol Identification Number
NCT04369092
Brief Title
Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia
Official Title
Myotonometric Assessment of Muscles in Multiple Sclerosis Patients With Dysphagia
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
October 2, 2019 (Actual)
Primary Completion Date
December 28, 2019 (Actual)
Study Completion Date
January 30, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Tuba Maden

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Multiple Sclerosis is a chronic inflammatory autoimmune neurological disease characterized by the destruction of myelin in the central nervous system, grey matter and axonal loss. The prevalence of neurogenic dysphagia in this group of patients is estimated to be more than 30%. The aim of this study was investigating of Masseter, Orbicularis Oris, Sternocleidomastoid muscles' viscoelastic properties in MS patients with and without swallowing problems.
Detailed Description
The aim of this study was investigating of Masseter, Orbicularis Oris, Sternocleidomastoid muscles' viscoelastic properties in MS patients with and without swallowing problems. It carried out that myotonometric assessment of muscles in multiple sclerosis patients with dysphagia and comparison of these properties.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis, Dysphagia, Swallowing Disorder, Deglutition Disorders, Muscle Tonus

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Arm Title
without swallowing problem
Arm Type
Other
Arm Description
patients without swallowing problem
Arm Title
mild swallowing problem
Arm Type
Other
Arm Description
patients with mild swallowing problem
Arm Title
severe swallowing problem
Arm Type
Other
Arm Description
patients with severe swallowing problem
Intervention Type
Other
Intervention Name(s)
DYMUS
Other Intervention Name(s)
evaluating oropharyngeal dysphagia
Intervention Description
DYsphagia in MUltiple Sclerosis (DYMUS) that was questionnare and Eating Assessment Tool (EAT-10) were used for assess swallowing problem. All individuals were classified according to DYMUS. The DYMUS Score was 1 or 2 was taken as mild swallowing problems, 3 or more was taken as severe swallowing problems. Patients were divided into three groups; first group that include patients without swallowing problems, second group that include patients with mild swallowing problems, third group that include severe swallowing problems.
Primary Outcome Measure Information:
Title
Myotonometric Measurement
Description
MyotonPro® device was used to measure muscles' viscoelastic parameters. The device is valid and reliable for measuring viscoelastic parameters (5, 6). Tonus, stiffness, elasticity of the muscles were recorded. Three measurements were bilaterally taken for each muscle. For each muscle, the average values of stiffness, tone and elasticity were retained as the main MyotonPRO outcomes. Myotonometric measurements were carried out for Masseter, Orbicularis Oris and Sternocleidomastoid (SKM) in supine position.
Time Frame
through study completion, average one hour
Secondary Outcome Measure Information:
Title
Eating Assessment Tool
Description
Eating Assessment Tool was used to assess symptom of dysphagia. EAT-10 consisted of ten items, each of items was scored from 0 to 4. As the score increases, the patient's symptoms become deterioration.
Time Frame
through study completion, average one hour

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: being diagnosed with Mc Donald's Multiple sclerosis (MS) in accordance with 2010 criteria, being between the ages of 18-45. Exclusion Criteria: having psychological, orthopedic and other neurological disorders, pregnancy, having had an attack in the last 3 months, application of botulinum toxin in the last 6 months.
Facility Information:
Facility Name
Hasan Kalyoncu University
City
Gaziantep
Country
Turkey

12. IPD Sharing Statement

Learn more about this trial

Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia

We'll reach out to this number within 24 hrs